Pharmaceutical Services Drive Waud Capital’s Latest Promotions

Waud Capital Partners places pharmaceutical services at the forefront with its latest leadership appointments. The Chicago-based investment firm has elevated Tim Cremieux to partner, highlighting its growing emphasis on pharmaceutical and medication supply chain investments.

Cremieux, who joined in 2017, has established himself as a central figure in the company’s strategic approach to pharmaceutical services. His recent leadership of the PharmAlliance platform investment demonstrates the commitment to building comprehensive pharmaceutical service networks. Additionally, his oversight of portfolio companies Apotheco and PromptCare showcases expertise in medication supply chain optimization.

The pharmaceutical services focus represents a significant evolution in the firm’s healthcare investment strategy. From its early days to its current position managing $4.6 billion in assets, the investment team has increasingly targeted specialized healthcare sectors that offer substantial growth potential.

The healthcare team’s pharmaceutical expertise extends beyond Cremieux’s promotion. Mike Lehman’s advancement to principal adds depth to the healthcare group’s capabilities, building on successes like their established platforms in the healthcare sector.

Since joining in 2021, Lehman has supported key healthcare investments, including work with Unifeye Vision Partners and the firm’s newest addition, Mopec Group. His promotion reflects the strategic vision for developing specialized expertise across multiple healthcare segments.

Leadership and growth continue to drive the firm’s investment strategy, with typical investments ranging from $75 million to $200 million in growth-oriented companies. This approach has supported the completion of more than 480 investments since its founding.

Looking ahead to 2025, the strengthened pharmaceutical services expertise provides a strong foundation for continued growth in this critical healthcare sector. As medication delivery and management systems become increasingly complex, the firm’s specialized knowledge and experienced leadership team create significant advantages in identifying and developing market-leading companies.